Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tandem Auto-Allo Transplant for Non-Hodgkin's Lymphoma
NCT00481832Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Jan 2007
- Primary completion
- Oct 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CD34+ hematopoietic progenitor cells in non-Hodgkin lymphoma (NHL), sponsored by Stanford University. Started Jan 2007; status: terminated.
02
Drugs
CD34+ hematopoietic progenitor cells
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00481832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00481832.